Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry

Tissue Antigens

Volumn 80, Issue 5, 2012, Pages 404-415

  Almahri, A ^a,b,c   Holgersson, J ^b   Alheim, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

Author keywords

Complement factor; Endothelial precursor cell crossmatch; Human leukocyte antigen antibodies; Lymphocyte crossmatch; Non human leukocyte antigen antibodies

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4D; COMPLEMENT FACTOR; COMPLEMENT FIXING ANTIBODY; IMMUNOGLOBULIN G; TIE 2 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOTOXICITY TEST; ENDOTHELIAL PRECURSOR CELL CROSSMATCH; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGLOBULIN DEPOSITION; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN BINDING; PURIFICATION; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE;

ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CELL DIFFERENTIATION; COMPLEMENT C1Q; COMPLEMENT C3C; COMPLEMENT C3D; COMPLEMENT C4B; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; PEPTIDE FRAGMENTS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84866933730     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01954.x     Document Type: Article

References (28)

1. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003: 3: 665-73.
2. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964: 204: 998-1000.
3. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969: 280: 735-9.
4. Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive HLA-specific antibodies in renal transplantation: contraindications vs. risk. Am J Transplant 2003: 3: 1488-500.
5. Amos DB, Bashir H, Bogle W et al. A simple microcytotoxicity test. Transplantation 1970: 7: 220-3.
6. Johnson AH, Rossen RD, Butler WT. Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of preformed antibodies in accelerated allograft rejection. Tissue Antigens 1972: 2: 215-26.
7. Thorne N, Klingman LL, Teresi GA et al. Effects of heat inactivation and DTT treatment of serum on immunoglobulin binding. Hum Immunol 1993: 37 (Suppl. 1): 123.
8. Okuno T, Kondelis N. Evaluation of dithiothreitol (DTT) for inactivation of IgM antibodies. J Clin Pathol 1978: 31: 1152-5.
9. Spiller OB. Measurement of C3 fragment deposition on cells. In: Methods in Molecular Biology, Vol. 150. Totowa, NJ: Humana Press Inc, 2000, 131-7.
10. Kushihata F, Watanabe J, Mulder A, Claas F, Scornik JC. Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004: 78: 995-1001.
11. Watanabe J, Scornik JC. Measuring human complement activation by HLA antibodies. Arch Pathol Lab Med 2006: 130: 368-73.
12. Ahern AT, Artruc SB, DellaPelle P et al. Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation 1982: 33: 103-6.
13. Cerilli J, Bay W, Brasile L. The significance of the monocyte crossmatch in recipients of living-related HLA identical kidney grafts. Hum Immunol 1983: 7: 45-50.
14. Kalil J, Guilherme L, Neumann J et al. Humoral rejection in two HLA identical living related donor kidney transplants. Transplant Proc 1989: 21: 711-3.
15. Amico P, Honger G, Bielmann D et al. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation 2008: 85: 1557-63.
16. Sumitran-Holgersson S, Holgersson J. Clinical importance of non-HLA antibodies in solid organ transplantation. Curr Opin Organ Transplant 2006: 11: 425-32.
17. Sumitran-Karuppan S, Tyden G, Reinholt F, Berg U, Möller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997: 5: 321-7.
18. Vermehren D, Sumitran-Holgersson S. Isolation of precursor endothelial cells from peripheral blood for donor-specific crossmatching before organ transplantation. Transplantation 2002: 74: 1479-86.
19. Nowak G, Karrar A, Holmen C et al. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 2004: 110: 3699-707.
20. Breimer ME, Rydberg L, Jackson AM et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009: 87: 549-56.
21. Alheim M, Johansson SM, Hauzenberger D, Grufman P, Holgersson J. A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells. Tissue Antigens 2010: 75: 269-77.
22. Pillemer L, Seifter S, Ecker EE. The role of the components of complement in specific immune fixation. J Exp Med 1942: 75: 421-35.
23. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today 1997: 18: 483-6.
24. Brooimans RA, Van der Ark AA, Tomita M, Van Es LA, Daha MR. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis. Eur J Immunol 1992: 22: 3135-40.
25. Asch AS, Kinoshita T, Jaffe EA, Nussenzweig V. Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J Exp Med 1986: 163: 221-6.
26. McNearney T, Ballard L, Seya T, Atkinson JP. Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest 1989: 84: 538-45.
27. Lobo PI, Winfield JB, Craig A, Westervelt FB Jr. Utility of protease-digested human peripheral blood lymphocytes for the detection of lymphocyte-reactive alloantibodies by indirect immunofluorescence. Transplantation 1977: 23: 16-21.
28. Johnson DR. Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C. Hum Immunol 2000: 61: 389-96.